On Apr. 22, 2020, ALung Technologies announced the U.S. Food and Drug Administration (FDA) granted the Company Emergency Use Authorization designation to the Hemolung Respiratory Assist System (RAS) for the treatment of Coronavirus Disease 2019 (COVID-19) patients.

ALung has treated numerous COVID-19 patients in the U.S. under existing FDA Emergency Use Provisions, and in the EU, where the Company was approved having been granted their CE Mark in 2013.